ARQT
Arcutis Biotherapeutics Inc
NASDAQ: ARQT · HEALTHCARE · BIOTECHNOLOGY
$22.37
-3.95% today
Updated 2026-04-29
Market cap
$2.91B
P/E ratio
—
P/S ratio
7.75x
EPS (TTM)
$-0.13
Dividend yield
—
52W range
$12 – $32
Volume
1.3M
Arcutis Biotherapeutics Inc (ARQT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $3.82M | $51.10M | $107.01M | $298.27M | $408.15M | $449.27M | $341.37M | $348.89M |
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Current assets | $3.82M | $51.10M | $106.47M | $292.83M | $402.77M | $437.41M | $330.43M | $335.82M |
| Total liabilities | $8.81M | $75.08M | $5.55M | $27.65M | $110.47M | $239.69M | $252.70M | $191.35M |
| Current liabilities | $692000.00 | $2.67M | $5.24M | $22.60M | $33.33M | $37.81M | $46.67M | $81.01M |
| Long-term debt | $966000.00 | — | — | — | $72.35M | $197.77M | $201.80M | $107.20M |
| Shareholder equity | — | — | — | — | — | — | — | — |
| Retained earnings | $-5.02M | $-24.28M | $-66.27M | $-201.95M | $-408.31M | $-719.76M | $-981.90M | $-1.12B |
| Accounts receivable | — | — | $145000.00 | $510000.00 | $362000.00 | $8.46M | $25.81M | $73.07M |
| Inventory | — | — | — | $-510000.00 | $1.18M | $7.51M | $13.13M | $14.53M |
| Goodwill | — | — | — | — | — | — | — | — |